CP 100356
modulates multidrug resistance; structure in first source
Also Known As:
CP-100356; CP100356; 2-Quinazolinamine, 4-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-6,7-dimethoxy-
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Fehling, Sarah Katharina:
1 article
(01/2021)
|
| 2. | Groseth, Allison:
1 article
(01/2021)
|
| 3. | Hirabayashi, Ai:
1 article
(01/2021)
|
| 4. | Kajikawa, Junichi:
1 article
(01/2021)
|
| 5. | Miyamoto, Sho:
1 article
(01/2021)
|
| 6. | Muramoto, Yukiko:
1 article
(01/2021)
|
| 7. | Nakano, Masahiro:
1 article
(01/2021)
|
| 8. | Noda, Takeshi:
1 article
(01/2021)
|
| 9. | Strecker, Thomas:
1 article
(01/2021)
|
| 10. | Takamatsu, Yuki:
1 article
(01/2021)
|
Related Diseases
Related Drugs and Biologics